How big is Pro-Dex, Inc.?

As of Jun 18, Pro-Dex, Inc. has a market capitalization of 139.02 million and reported net sales of 64.12 million with a net profit of 9.37 million over the latest four quarters.

Market Cap: As of Jun 18, Pro-Dex, Inc. has a market capitalization of 139.02 million, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Pro-Dex, Inc. reported net sales of 64.12 million and a net profit of 9.37 million.<BR><BR>Balance Sheet Snapshot: As of Jun 24, the company reported shareholder's funds of 30.87 million and total assets of 54.21 million.

What does Pro-Dex, Inc. do?

Pro-Dex, Inc. designs and manufactures surgical and dental instruments and motion control products, classified as a micro-cap company in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $17 million and a net profit of $3 million, with a market cap of $139.02 million.

Overview: <BR>Pro-Dex, Inc. designs and produces surgical and dental instruments and motion control products, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 17 Million (Quarterly Results - Mar 2025) <BR>Net Profit: 3 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 139.02 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.25 <BR>Return on Equity: 25.14% <BR>Price to Book: 3.94<BR><BR>Contact Details: <BR>Address: 2361 McGaw Ave, IRVINE CA: 92614 <BR>Tel: 1 949 7693231 <BR>Fax: 1 800 5626204 <BR>Website: http://www.pro-dex.com/

Should I buy, sell or hold Pro-Dex, Inc.?

Who are in the management team of Pro-Dex, Inc.?

As of March 2022, the management team of Pro-Dex, Inc. includes Mr. Nicholas Swenson (Independent Chairman), Mr. Richard Van Kirk (President and CEO), Ms. Katrina Philp, and independent directors Mr. Raymond Cabillot, Mr. William Farrell, and Mr. David Hovda.

As of March 2022, the management team of Pro-Dex, Inc. includes the following individuals:<BR><BR>- Mr. Nicholas Swenson: Independent Chairman of the Board<BR>- Mr. Richard Van Kirk: President, Chief Executive Officer, Chief Operating Officer, Director<BR>- Ms. Katrina Philp: Director<BR>- Mr. Raymond Cabillot: Independent Director<BR>- Mr. William Farrell: Independent Director<BR>- Mr. David Hovda: Independent Director

Is Pro-Dex, Inc. technically bullish or bearish?

As of September 5, 2025, Pro-Dex, Inc. has shifted to a mildly bearish trend due to a bearish MACD and moving averages, despite a bullish weekly RSI, with significant underperformance compared to the S&P 500.

As of 5 September 2025, the technical trend for Pro-Dex, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a bearish signal from the daily moving averages. The weekly RSI remains bullish, but the overall indicators, including the KST and Dow Theory, suggest a bearish sentiment. Additionally, the stock has underperformed the S&P 500 over the past month and year-to-date, with returns of -21.18% and -25.65% respectively, compared to the S&P's 2.33% and 12.22%.

Is Pro-Dex, Inc. overvalued or undervalued?

As of October 17, 2025, Pro-Dex, Inc. is considered very attractive due to its undervalued status, with strong metrics like a P/E ratio of 16 and a PEG ratio of 0.18, outperforming peers with negative P/Es and showing potential for recovery despite a lower return compared to the S&P 500.

As of 17 October 2025, the valuation grade for Pro-Dex, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. Based on the current metrics, the company appears undervalued. Key ratios supporting this assessment include a P/E ratio of 16, an EV to EBITDA of 11.51, and a PEG ratio of 0.18, all of which suggest that the stock is trading at a discount relative to its earnings growth potential.<BR><BR>In comparison to its peers, Pro-Dex, Inc. has a significantly better valuation profile with a P/E of 14.77, while its nearest competitors, such as Prenetics Global Ltd. and Wrap Technologies, Inc., are classified as risky with negative P/Es. Furthermore, the company's return over the past three years of 31.53% contrasts sharply with the S&P 500's return of 81.19%, highlighting a potential for recovery and growth.